drugset / Trial / NCT02564367
Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction
Phase 1/2
Completed
30 enrolled
AIO-Studien-gGmbH
Nordic Pharma SAS · collabTaiho Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
Multicenter trial in Germany: Feasibility Study of Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction with the aim to show the feasibility and tolerability of adjuvant S-1 treatment in Caucasian patients and to determine the recommended dose for the treatment regimen.
Timeline
- Start
- 2015-10-06
- Primary completion
- 2019-03-01
- Completion
- 2020-03-06